US Patent Issued to Secura Bio on April 21 for "Treatment of cancers using PI3 kinase isoform modulators" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,387, issued on April 21, was assigned to Secura Bio Inc. (Las Vegas).

"Treatment of cancers using PI3 kinase isoform modulators" was invented by Daniel Paterson (Needham, Mass.), Jonathan A. Pachter (Wayland, Mass.), Hagop Youssoufian (Boston) and Stephanie Lustgarten (Needham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein, at least in part, are methods of treating a hematologic malignancy in a human subject in need thereof, comprising orally administering to the subject duvelisib or a pharmaceutically acceptable form thereof."

The patent was filed on July 24, 2020, under Application No. 18/017,631.

*For further information...